AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid
PHASE3
The primary purpose of this study is to determine whether treatment with le...
An Observational Study on Lecanemab Treatment for Early Alzheimer's Disease
N/A
The goal of this observational study is to valuate the sensitivity and spec...
Status
Recruiting
Location
The First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT07153848
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
PHASE2
To assess the safety, tolerability, biomarker, cognitive, and clinical effi...
The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.
PHASE2
The goal of the trial is to see if the Safety and Tolerability of X/T+X/T-E...
Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)
N/A
The purpose of this research is to investigate the long-term effectiveness ...
Status
Recruiting
Location
Gachon University Gil medical Center
Start Date
2025-02-24
Trial ID
NCT06889818
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy
EARLY_PHASE1
The purpose of this study is to assess the safety and feasibility of admini...
Status
Active Not Recruiting
Location
West Virginia University Rockefeller Neuroscience Institute